Building 3 has been integral to the development of virtually every biotherapeutic produced by Genentech.
Originally constructed in 1981, this vital facility has undergone significant transformation and aging over the years necessitating a comprehensive rehabilitation plan. Eichleay was initially engaged to manage a portfolio of thrity-eight projects with a total installed cost (TIC) of approximately $250 million to extend reliable production of this facility through the year 2020. A Program structure was the best fit for the management of these technically, functionally, and spatially interrelated projects.
total installed cost (TIC)
Building 3 Program Management
Eichleay excels at efficiently executing technically complex, fast-track projects that involve many disciplines.
Save money, reduce risk, and speed completion of your project with Eichleay. Contact us to learn how our talented team of versatile professionals could help you.
Transparency in Coverage (Federal ID: 26-1194667)